Gastrointestinal experts explore the benefits of the drug when treating patients with acute severe ulcerative colitis.
Crohn's and Colitis
Study in people taking a biologic drug for autoimmune diseases shows association of patient support programs with reduced chance of starting opioid pain medicines or continuing on them.
Studies suggest the gut microbiome can influence immunotherapy side effects. Butyrate emerges as an intriguing candidate against inflammation in the colon.
A tiny arms race playing out inside the gut could eventually offer a new way to treat out-of-balance microbiomes.